在患有重度抑郁症的年轻成年人中,使用药物事件监测系统的药物坚持
Jia Xu1, Weiwei Zhao1, Pan Lin1
1Department of Psychiatry, the Affiliated Brain Hospital of Nanjing Medical University, Nanjing City, Jiangsu Province, China.
Issues in mental health nursing
|February 19, 2026
概括
患有严重抑郁症 (MDD) 的年轻人对药物坚持程度受到诸如再入院和副作用等因素的影响. 老年,自我耻辱和负面的药物态度预测了较低的坚持,有助于风险评估.
科学领域:
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 药物坚持对于管理严重抑郁症 (MDD) 至关重要.
- 了解初发年轻患者的坚持预测因素对于有效治疗至关重要.
- 低坚持可以导致复发和更糟糕的长期结果在青少年和年轻成年人MDD.
研究的目的:
- 确定与MDD第一个发作的年轻患者药物坚持相关的社会人口统计学,临床和患者报告的因素.
- 开发一个预测模型,用于识别高风险不遵守的个体.
- 为改善该群体的药物坚持提供临床策略的信息.
主要方法:
- 预期招募512名患有首发MDD的年轻患者.
- 使用药物事件监测系统 (MEMS) 追踪了30天的药物坚持.
- 对社会人口因素,临床变量和患者报告的得分进行二进制后勤回归分析.
主要成果:
- 69.3%的患者实现了MEMS的坚持.
- 低坚持的风险增加与再入院,药物度超出治疗范围和严重的副作用有关.
- 老年,更高的自我耻辱评分和负面的药物态度是低坚持的重要预测因素.
- 预后指数>0.800表明患有低坚持症的风险很高.
结论:
- 几个因素显著影响年轻MDD患者的药物坚持.
- 一个预测公式可以识别高风险个体,从而实现有针对性的干预.
- 通过临床风险评估来改善MDD的遵守是改善年轻人群MDD管理的关键.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
991
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
991
01:28Drug Therapy
316
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
316
01:29Therapeutic Drug Monitoring: Affecting Factors
264
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
264
01:27Depressive Disorders: MDD and Dysthymia
858
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
858
01:25Antidepressant Drugs: Overview
1.7K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.7K
01:16Therapeutic Drug Monitoring: Overview and Classification
398
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
398